Evidence map›Paper›PMID 21637794›Full record

ArticlePLoS genetics2011

Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue.

Federico Innocenti, Gregory M Cooper, Ian B Stanaway, Eric R Gamazon, Joshua D Smith, Snezana Mirkov, Jacqueline Ramirez, Wanqing Liu, Yvonne S Lin, Cliona Moloney and 10 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 13 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 13 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 6 countries.

Federico InnocentiCancer Research Center, Committee on Clinical Pharmacology and Pharmacogenomics, Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Gregory M Cooper
Ian B Stanaway
Eric R Gamazon
Joshua D Smith
Snezana Mirkov
Jacqueline Ramirez
Wanqing Liu
Yvonne S Lin
Cliona Moloney
Shelly Force Aldred
Nathan D Trinklein
Erin Schuetz
Deborah A Nickerson
Ken E Thummel
Mark J Rieder
Allan E Rettie
Mark J Ratain
Nancy J Cox
Christopher D Brown
University of Chicago · USHuman Genome Sciences (United States) · USUniversity of Washington · USID Genomics (United States) · USArgonne National Laboratory · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USSt. Jude Children's Research Hospital · USUniversity of Illinois Chicago · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
Whole GenomeU01GM061393 · NIGMS · UNIVERSITY OF CHICAGO · PI RATAIN, MARK J · 2000 to 2014
$39.0M
UW-FHCRC VARIATION DISCOVERY RESOURCEU01HL066682 · NHLBI · UNIVERSITY OF WASHINGTON · PI NICKERSON, DEBORAH A · 2000 to 2007
$19.1M
TOXIC DRUG INTERACTIONS WITH VALPROIC ACIDP01GM032165 · NIGMS · UNIVERSITY OF WASHINGTON · PI RETTIE, ALLAN EDWARD · 1985 to 2012
$18.3M
Institute for Translational Health Science (KL2)KL2RR025015 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$9.3M
Genetic Predictors of Human Liver CYP Expression & ActivityR01GM094418 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SCHUETZ, ERIN G · 2010 to 2013
$1.4M
Genetic Factors Influencing Warfarin DoseR01NS053646 · NINDS · UNIVERSITY OF WASHINGTON · PI RIEDER, MARK J · 2006 to 2008
$1.1M
Genome-Wide molecular epidemiology of treatment outcome and cancer riskK07CA140390 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI INNOCENTI, FEDERICO · 2009 to 2013
$648k
Genome-wide SNP genotyping and expression analysis in human liversR21DK081157 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI INNOCENTI, FEDERICO · 2009 to 2010
$596k
NCI NIH HHS K07 CA140390NCI NIH HHS K07CA140390-01NCI NIH HHS P30 CA014599NCRR NIH HHS 1KL2RR025015NCRR NIH HHS KL2 RR025015NHLBI NIH HHS U01 HL066682NHLBI NIH HHS U01 HL66682NIDDK NIH HHS N01-DK-7-0004/HHSN267200700004CNIDDK NIH HHS R21 DK081157NIDDK NIH HHS R21DK081157-01A2NIGMS NIH HHS P01 GM032165NIGMS NIH HHS P01 GM32165NIGMS NIH HHS R01 GM094418NIGMS NIH HHS R01GM094418NIGMS NIH HHS U01 GM061393NIGMS NIH HHS U01 GM61393NINDS NIH HHS NS053646NINDS NIH HHS R01 NS053646NLM NIH HHS HHSN267200700004CNLM NIH HHS HHSN267200700004G
6 · The paper itself

Abstract

The discovery of expression quantitative trait loci ("eQTLs") can help to unravel genetic contributions to complex traits. We identified genetic determinants of human liver gene expression variation using two independent collections of primary tissue profiled with Agilent (n = 206) and Illumina (n = 60) expression arrays and Illumina SNP genotyping (550K), and we also incorporated data from a published study (n = 266). We found that ∼30% of SNP-expression correlations in one study failed to replicate in either of the others, even at thresholds yielding high reproducibility in simulations, and we quantified numerous factors affecting reproducibility. Our data suggest that drug exposure, clinical descriptors, and unknown factors associated with tissue ascertainment and analysis have substantial effects on gene expression and that controlling for hidden confounding variables significantly increases replication rate. Furthermore, we found that reproducible eQTL SNPs were heavily enriched near gene starts and ends, and subsequently resequenced the promoters and 3'UTRs for 14 genes and tested the identified haplotypes using luciferase assays. For three genes, significant haplotype-specific in vitro functional differences correlated directly with expression levels, suggesting that many bona fide eQTLs result from functional variants that can be mechanistically isolated in a high-throughput fashion. Finally, given our study design, we were able to discover and validate hundreds of liver eQTLs. Many of these relate directly to complex traits for which liver-specific analyses are likely to be relevant, and we identified dozens of potential connections with disease-associated loci. These included previously characterized eQTL contributors to diabetes, drug response, and lipid levels, and they suggest novel candidates such as a role for NOD2 expression in leprosy risk and C2orf43 in prostate cancer. In general, the work presented here will be valuable for future efforts to precisely identify and functionally characterize genetic contributions to a variety of complex traits.

Indexed as

Genome, HumanPolymorphism, Single NucleotideQuantitative Trait Loci3' Untranslated RegionsAge FactorsBlack PeopleChromosome MappingCloning, MolecularFemaleGene Expression ProfilingGenetic VectorsGenome-Wide Association StudyGenotypeHep G2 CellsHispanic or LatinoHumans3' Untranslated Regions

Identifiers

PMID21637794
PMCPMC3102751
OpenAlexW2001320379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.